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KAPOSI'S SARCOMA AND COEXISTENT GIANT FOLLICULAR LYMPHOBLASTOMA
Various reports of coexistent Kaposi's sarcoma and malignant lymphomas
have appeared in the literature." This combination occurs with a greater
frequency than would be predicted on the basis of random association.
The two diseases may appear both as anatomically separate lesions and as
a mixture of the two lesions in the same specimen of skin or lymph node,
suggesting that there may be a transition from one type of tumor into the
other, or that they may have a common precursor, such as the reticulum
cell.' Reports of giant follicular lymphoblastoma in association with Kaposi's
sarcoma have been rare, only two cases having been previously described
in the literature, by Pack and Davis in 1954.2
A patient has been encountered who demonstrates this interesting
association. He first developed typical clinical and histologic features of
giant follicular lymphoblastoma, and subsequently developed widespread
cutaneous and visceral lesions of Kaposi's sarcoma. This case is of par-
ticular interest because the cause of death was the rapidly progressive
visceral Kaposi's sarcoma rather than the malignant lymphoma.
CASE REPORT
A 63-year old white male (#A-5724) was admitted to the San Fran-
cisco Veterans Administration Hospital on August 11, 1960 for evalua-
tion of enlarged right supraclavicular lymph nodes which had been
present for eight months. He felt weak and complained of a recent increase
in his chronic cough, attacks of vertigo, nocturnal dyspnea, severe scrotal
pruritis, and attacks of right shoulder pain radiating down the right arm,
associated with tingling and weakness in his right hand. Previous biopsy
of one of the enlarged right supraclavicular lymph nodes revealed an in-
crease in size and number of follicles, with peripheral packing of small
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lymphocytes. This was considered suggestive of the diagnosis of malignant
lymphoma.
The patient did not appear ill. Large, rubbery, moderately tender, freely
movable lymph nodes were noted in the right posterior cervical, supra-
clavicular, axillary, and femoral areas. The lungs were normal. A soft
systolic ejection murmur was heard at the cardiac apex. The liver was
tender and extended 2 cm. below the right subcostal margin. There was
decreased pain and touch sensation and weakness in the right forearm and
hand.
Complete blood count, sedimentation rate, and platelet count were
normal, as were the serum creatinine, acid and alkaline phosphatase, and
albumin and globulin. The uric acid was 6.1 mg. per 100 ml. Fasting blood
sugar was 128 mg. per 100 ml. and a two hour postprandial blood sugar
was 101 mg. per 100 ml. Chest X-ray revealed multiple punctate calcific
densities distributed throughout both lung fields, consistent with residues
of old inflammatory disease. There was no hilar lymphadenopathy, media-
stinal involvement, or evidence of acute pulmonary disease. An intravenous
pyelogram was normal. Bone marrow examination showed a slight increase
in reticulum and plasma cells, but no evidence of lymphomatous infiltra-
tion.
It was felt that the patient had a malignant lymphoma, with involvement
of the right brachial plexus. A supraclavicular lymph node removed for
biopsy (Fig. 1) presented a histologic pattern similar to that seen in the
lymph node excised several months earlier. The pathologic diagnosis
was giant follicular lymphoblastoma. After treatment with nitrogen mustard
the lymphadenopathy diminished markedly in all areas. The patient's mild
diabetes was controlled with tolbutamide and he was discharged one
month after admission.
He was rehospitalized one week later complaining of nausea and vomit-
ing, weakness, and a mild fever for three days. He was found to have
a temperature of 100.40 F., a pulse of 105, and an erythematous macular
rash over the shoulders and trunk. There was a right pleural effusion and
the liver was enlarged 6 cm. below the right subcostal margin. The spleen
tip was now palpable and multiple soft lymph nodes up to 3 cm. in diameter
were noted in the neck, axilla, and groin bilaterally. The white blood cell
count was 3,100 per mm3, with 80 per cent neutrophils, 8 per cent lympho-
cytes, and 12 per cent monocytes. The hemoglobin concentration was 11.2
gm/100 ml. and the hematocrit reading was 34 per cent. The platelet count
was 144,000 per mm3. Tests of liver function were normal. A PPD skin
test was negative. Twenty milliliters of chylous fluid were removed from
the right pleural space. The patient was then given chlorambucil, 10 mg.
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Volume 38,April, 1966FIG. 1. Supraclavicular lymph node showing increase in nutmber and size of follicles
typical of gianlt follicular lymphoblastoma. Hematoxylini and eosin stain, X 48.FIG. 2. Lesions of Kaposi's sarcoma: A., upper left: Iinfiltratinig small intestine (X 48);
B., upper right: Surroundinig coronary artery (X 48); C., lower left: Obliterating lung
parenchyma (X48) and D., lower right: In peri-adrenal tissues, showing both fibroblastic
and angiomatous patterns (X 220). All sections stained with hematoxylin and eosin. (K =
Kaposi's sarcoma; C = coronary artery).FIG. 3. Retroperitoneal lymph node obtained at autopsy showing Kaposi's sarcoma
(K) infiltrating a node containinig malignanit lymphoma (L). Hematoxylin atn(d
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daily. He gained weight, felt symptomatically improved, and was dis-
charged. Treatment with chlorambucil was discontinued four weeks later
due to leukopenia.
The patient was admitted for the third time two weeks later, com-
plaining of vomiting and lower abdominal pain and tenderness. He appeared
chronically ill but no lymphadenopathy was apparent. The left lobe of the
liver was now palpable. Chest X-ray revealed bilateral pleural effusions.
Barium enema and intravenous pyelogram were normal. Hematologic
studies were unchanged. Thoracentesis yielded 445 ml. of chylous fluid.
He was treated with benzcarbimine (AB-103), an alkylating agent,' and
blood transfusions. Following each transfusion there was evidence of
increased hemolysis, and he was therefore given prednisone, 40 mg. daily,
later reduced to 30 mg. daily. At the time of discharge three months after
admission his hemoglobin, white blood-cell count, and platelet count were
stable. Repeat chest X-ray showed clearing of the bilateral pleural effusions.
There was no change in the multiple punctate calcific densities noted
previously, and no evidence of any acute disease process.
He was readmitted for the fourth and final time one week later, com-
plaining of weakness, left chest pain, attacks of vertigo, and daily fevers
to 1010 F. He weighed 158 pounds, 10 pounds less than his weight on the
first admission. He had noted an eruption of tender, blue-violet nodules
over his chest. There was generalized lymphadenopathy, including large,
palpable retroperitoneal lymph nodes. There were bilateral pleural effusions
and the spleen had enlarged 4 cm. below the left subcostal margin. The
white blood-cell count was 4,400 per mm3, the hematocrit reading had
fallen to 25 per cent, and the platelet count was 53,000 per mm3. Multiple
sputum and pleural fluid cultures for tubercle bacilli were negative.
Biopsy of one of the skin lesions was reported as, "dermal vascular
proliferation with moderate perivascular fibroplasia and hemorrhage. These
changes could conceivably reflect early Kaposi's sarcoma. There is no indi-
cation of mycosis fungoides." During the next several weeks the skin lesions
spread to involve a large part of the trunk, and were considered too
extensive to permit effective radiation therapy.
Insulin was now required for control of his diabetes. Thoracentesis
yielded 850 ml. of bloody sterile fluid on two occasions. Pancytopenia con-
tinued to be a major problem. In an attempt to control the rapidly pro-
gressing lymphoma, the patient was treated with cyclophosphamide, 200
mg. daily for seven days, without benefit. The dose of prednisone was
increased to 1,000 mg. daily for seven days. There was a transient rise in
hemoglobin concentration and white blood-cell count, but the thrombocy-
topenia was unchanged. He became progressively weaker and unresponsive,
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and expired 10 months after his first hospital admission and 18 months
after the onset of symptoms.
At postmortem examination there were multiple dark-purple papules
over the trunk and arms. There were no lesions on the legs. Similar tumor
nodules were found in the retroperitoneal area, surrounding the major
branches of the abdominal aorta, in the wall of the stomach, small in-
testine (Fig. 2A) and colon, and in the liver, heart (Fig. 2B), kidneys,
lungs (Fig. 2C), adrenal glands (Fig. 2D), and the prostate gland. The
central nervous system was free of tumor.
The multiple tumor nodules found throughout the body showed a con-
sistent pattern of dense sheets of fibroblasts, interstitial hemorrhage,
and occasional collections of thin-walled, small, congested blood vessels.
The neoplasm showed a tendency to surround nerves and blood vessels
and produced the characteristic herringbone pattern seen in fibroblastic
tumors. Although the nodules tended to be discrete, there was infiltration
of surrounding tissues. In the skin, the tumor tended to surround sweat
glands and other skin appendages.
There were enlarged lymph nodes along the thoracic and abdominal
aorta. One retroperitoneal node showed many large primitive lymphoid
cells in an area immediately adjacent to a Kaposi's lesion (Fig. 3). A
few large abnormal reticulum cells were seen in association with the
primitive lymphoid cells. The spleen was large but showed no evidence
of tumor. The bone marrow showed mild erythroid hyperplasia. The peri-
toneal and pleural spaces contained large bloody effusions. Several hemor-
rhagic Kaposi's tumor nodules were present in the lung parenchyma,
tending to surround pulmonary vessels and bronchi. Throughout both
lungs there were many hard nodules averaging two to three millimeters
in size, which on section were areas of fibrosis and old healed tubercles.
There were hemorrhages in the skin of the lower legs and the peritoneal
surfaces, and the abdominal viscera were matted together by indurated,
hemorrhagic, mesenteric and omental fat.
DISCUSSION
This case presents the interesting finding of lesions of Kaposi's hemor-
rhagic sarcoma in most of the internal organs. The initial pathologic
diagnosis, however, was giant follicular lymphoblastoma, based upon two
lymph-node biopsies performed several months apart. The skin lesions
were at first thought to represent mycosis fungoides, since they appeared
on the trunk, an unusual presentation for Kaposi's sarcoma. Skin biopsy,
subsequent clinical course, and autopsy examination established the second
diagnosis of Kaposi's sarcoma.
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The usual life expectancy in Kaposi's sarcoma is 8 to 10 years, al-
though some patients have survived for 25 years. It is generally a slowly
progressive disease that does not usually cause the patient's death.' It
has been emphasized recently that Kaposi's sarcoma is not always slowly
progressive and that in the presence of visceral involvement, which occurs
in about 10 per cent of cases, the disease frequently has a more rapid course,
with hemorrhagic effusions being common.' The most frequent location
for visceral lesions is the gastrointestinal tract, but any organ may be
affected. In a patient with typical skin lesions, the presence of unexplained
anemia, lymphadenopathy, hepatomegaly, or splenomegaly should suggest
the likelihood of visceral involvement, which may precede skin involvem'ent
or occur in its absence.
The disease most commonly begins with tender, red to purple, or blue
macules on the upper or lower extremities. In the series reported by
McCarthy and Pack,8 the earliest lesions were on the extremities in 87 per
cent of cases. These lesions slowly develop into nodules, which may
coalesce. Histologically there are three more or less distinct stages: in-
flammatory, granulomatous, and sarcomatous. In the earliest stage there
are dilated dermal vessels surrounded by round and connective tissue cells.
Edema and hemorrhage are minimal. In later stages connective tissue
proliferation and the growth of endothelial cells form vessel sinuses re-
sembling hemangiomas. New vessel formation is imperfect, thus permitting
the escape of blood into tissues. In the advanced stages the characteristic
picture is one of spindle-cell sarcoma interspersed with hemangiomatous
elements. The usual lesion shows varying combinations of the inflammatory,
angiomatous, and sarcomatous patterns in different areas of the same
specimen. Hyperplasia of the reticuloendothelial system, with lymphadeno-
pathy, hepatomegaly, and splenomegaly, is frequently present.
Most workers agree that the Kaposi lesion is a sarcoma, but there is
disagreement as to cell origin and ability of the tumor to metastasize. It
is generally regarded as a neoplasm that arises multicentrically from the
undifferentiated perivascular tissues. In the present case visceral lesions
tended to surround blood vessels. Tedeschi9 believes it to be mesenchymal in
origin, springing from the primitive reticulum cell. Pepler'0 demonstrated
acid phosphatase and pseudocholinesterase in the tumor cells in six cases,
thus supporting the theory that the tumor is of neural origin.
Giant follicular lymphoblastoma is closely related to lymphosarcoma
and is characterized by the striking histologic picture of huge lymphoid
follicles in various organs. The cell type may vary from cells resembling
mature lymphocytes to large lymphoblasts. The histologic appearance fre-
quently changes during the course of the disease. In the series of 25 cases
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reported by Hurst and Meyer,' 7 developed Hodgkin's disease, 4 developed
lymphosarcoma, 2 developed reticulum cell sarcoma, and 10 showed
no change at the time of autopsy. Therapeutic benefit may be achieved
with irradiation and various cytotoxic agents.
In the present case, histologic evidence for both Kaposi's sarcoma and
giant follicular lymphoblastoma was present. There were hemorrhagic
Kaposi's tumor nodules in most organs, with hemorrhagic pleural and peri-
toneal effusions. Although the diagnosis of giant follicular lymphoblastoma
was made on two separate node biopsies and the patient had widespread
lymphadenopathy during the course of his disease, only a single retro-
peritoneal lymph node still showed histologic evidence of lymphoma at his
death. In this particular node there were many large primitive lymphoid
cells immediately adjacent to a lesion of Kaposi's sarcoma that was pene-
trating the lymph node capsule. It is possible that massive prednisone
therapy shortly before death markedly reduced the extent of the lymphoma.
The relationship between Kaposi's sarcoma and the malignant lymphomas
has been the subject of much discussion. Allen! reviewed 8 cases of
coexistent Kaposi's sarcoma and malignant lymphoma, in which 4 had
Hodgkin's disease, 2 had mycosis fungoides, 1 had lymphosarcoma, and
1 had reticulum cell sarcoma. A common finding was masses of lymphocytes
that appeared to be integral components of the angiosarcoma and were
particularly prominent at its advancing edge. It has been postulated that
neoplastic lymphocytic or reticulum cells were transformed into the vascular
channels of Kaposi's sarcoma. Cox and Helwig'l note the apparent higher
incidence of malignant lymphoma and leukemia in association with Kaposi's
sarcoma, but feel that neither the clinical nor the pathologic features justify
the classification of Kaposi's sarcoma as a malignant lymphoma or a
reticuloendothelial disease. This opinion is shared by most authorities.
Most patients with both diseases die of the lymphoma or leukemia, not the
Kaposi's sarcoma.
Hurlbut and Lincolne noted that 6 of 13 cases of Kaposi's sarcoma
had diabetes mellitus. In the present case the patient had mild diabetes
at the onset, perhaps later made worse by the corticosteroids used in
treatment. At autopsy the pancreas was atrophic, with replacement by
fat, and showed one focus of involvement by Kaposi's sarcoma.
SUMMARY
A patient with giant follicular lymphoblastoma of 16-months' duration
developed Kaposi's hemorrhagic sarcoma which resulted in his death two
months later. He was treated with various cytotoxic drugs, which ap-
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parently induced a remission in the malignant lymphoma but proved
ineffective against the widespread cutaneous and visceral K,aposi's hemor-
rhagic sarcoma. He illustrates the increased incidence of coexistent Kaposi's
sarcoma and malignant lymphoma and the manifestations of widespread
visceral involvement by Kaposi's sarcoma. The interesting question regard-
ing possible relationship of the two diseases has been reviewed.
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